IP Library Granted Patent US 9,222,094
Granted Patent B2
US 9,222,094 · App. 14/226,573 · Granted Dec 29, 2015

Thermophilic and thermoacidophilic metabolism genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods

Inventors: Vicki S Thompson (Idaho Falls, ID); William A Apel (Jackson, WY); David William Reed (Idaho Falls, ID); Brady D Lee (Idaho Falls, ID); David N Thompson (Idaho Falls, ID); Francisco F Roberto (Highlands Ranch, CO); Jeffrey A Lacey (Idaho Falls, ID)
Assignee: BATTELLE ENERGY ALLIANCE, LLC
C12N15/75C12N9/00C12N9/1029
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,222,094
App. No.
14/226,573
Granted
Dec 29, 2015
Kind
B2
Abstract

Isolated and/or purified polypeptides and nucleic acid sequences encoding polypeptides from Alicyclobacillus acidocaldarius are provided. Further provided are methods for modulating or altering metabolism in a cell using isolated and/or purified polypeptides and nucleic acid sequences from Alicyclobacillus acidocaldarius.

Claims (9)

1. An expression vector comprising an isolated polynucleotide encoding a polypeptide having at least 90% sequence identity to SEQ ID No. 392.

2. The expression vector of claim 1 , wherein the expression vector comprises a polynucleotide having at least 90% identity to SEQ ID No. 393.

3. The expression vector of claim 1 , wherein the encoded polypeptide has Acetyl-CoA C-acetyltransferase enzymatic activity.

4. An expression vector comprising an isolated polynucleotide encoding a polypeptide having at least 95% sequence identity to SEQ ID No. 392.

5. The expression vector of claim 4 , wherein the encoded polypeptide has Acetyl-CoA C-acetyltransferase enzymatic activity.

6. The expression vector of claim 4 , wherein the expression vector comprises a polynucleotide having at least 95% identity to SEQ ID No. 393.

7. A method of modulating or altering metabolism in a cell, the method comprising:

providing the expression vector of claim 3 to the cell and expressing the encoded polypeptide in the cell.

8. The method according to claim 7 , further comprising glycosylating, or otherwise post-translationally modifying the encoded peptide in the cell.

Assignments (1)
CONFIRMATORY LICENSE Recorded Nov 21, 2014
From: BATTELLE ENERGY ALLIANCE, LLC
To: ENERGY, UNITED STATES DEPARTMENT OF
Reel/Frame 034355/0564 →
Continuity (3)
Division 12380551 · Feb 26, 2009
Provisional Application 61032339 · Feb 28, 2008
Related Publication 20140227788A1 · Aug 14, 2014